| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 22 | 2015 | 3390 | 1.630 |
Why?
|
| Genes, Immunoglobulin | 17 | 2000 | 287 | 1.460 |
Why?
|
| B-Lymphocytes | 29 | 2013 | 4739 | 1.450 |
Why?
|
| Chemokines, CXC | 10 | 2007 | 421 | 1.360 |
Why?
|
| Focal Adhesion Kinase 1 | 5 | 2012 | 119 | 1.210 |
Why?
|
| Immunoglobulin Variable Region | 15 | 1999 | 419 | 1.210 |
Why?
|
| Stem Cell Niche | 4 | 2017 | 346 | 1.060 |
Why?
|
| Immunoglobulin Heavy Chains | 15 | 2000 | 649 | 1.010 |
Why?
|
| Lymphopoiesis | 3 | 2012 | 133 | 0.880 |
Why?
|
| Hematopoiesis | 12 | 2020 | 2063 | 0.840 |
Why?
|
| Bone Marrow | 11 | 2020 | 2918 | 0.830 |
Why?
|
| Agglutinins | 13 | 1995 | 28 | 0.800 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 5 | 2009 | 186 | 0.780 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 14 | 1995 | 146 | 0.750 |
Why?
|
| Chemotaxis | 8 | 2016 | 598 | 0.720 |
Why?
|
| Receptors, CXCR4 | 6 | 2007 | 728 | 0.580 |
Why?
|
| Blood Transfusion | 7 | 2020 | 1328 | 0.540 |
Why?
|
| Autoantibodies | 15 | 2000 | 2119 | 0.530 |
Why?
|
| Rh-Hr Blood-Group System | 9 | 2018 | 65 | 0.500 |
Why?
|
| Cell Adhesion | 9 | 2009 | 3096 | 0.490 |
Why?
|
| Platelet Transfusion | 3 | 2016 | 294 | 0.460 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 6 | 1999 | 91 | 0.460 |
Why?
|
| Erythrocytes | 9 | 2018 | 2415 | 0.460 |
Why?
|
| Receptors, Chemokine | 3 | 2006 | 654 | 0.460 |
Why?
|
| Chemokine CXCL12 | 11 | 2015 | 454 | 0.450 |
Why?
|
| Kell Blood-Group System | 1 | 2013 | 21 | 0.450 |
Why?
|
| Isoantibodies | 3 | 2013 | 661 | 0.430 |
Why?
|
| Bone Marrow Cells | 8 | 2017 | 2424 | 0.430 |
Why?
|
| Neutrophils | 10 | 2021 | 3770 | 0.430 |
Why?
|
| Lymphoma, AIDS-Related | 3 | 2000 | 79 | 0.420 |
Why?
|
| Arterioles | 1 | 2013 | 250 | 0.420 |
Why?
|
| Mesenchymal Stem Cells | 5 | 2017 | 1634 | 0.410 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2005 | 241 | 0.410 |
Why?
|
| Anemia, Hemolytic | 1 | 2013 | 163 | 0.410 |
Why?
|
| Immunoglobulin M | 11 | 2006 | 1529 | 0.400 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 6 | 2021 | 628 | 0.390 |
Why?
|
| Colony-Forming Units Assay | 4 | 2013 | 351 | 0.380 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 223 | 0.350 |
Why?
|
| Blood Platelets | 5 | 2018 | 2522 | 0.350 |
Why?
|
| Granulocytes | 4 | 2017 | 551 | 0.330 |
Why?
|
| Complement C3a | 2 | 2005 | 66 | 0.320 |
Why?
|
| I Blood-Group System | 5 | 1995 | 8 | 0.320 |
Why?
|
| Blood Group Antigens | 4 | 2015 | 187 | 0.290 |
Why?
|
| Plasma Exchange | 6 | 1987 | 158 | 0.290 |
Why?
|
| Immunoglobulin Idiotypes | 6 | 1995 | 200 | 0.290 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2007 | 98 | 0.280 |
Why?
|
| Antigens, Human Platelet | 2 | 2018 | 41 | 0.280 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2009 | 431 | 0.280 |
Why?
|
| Myeloid Cells | 7 | 2017 | 821 | 0.280 |
Why?
|
| Models, Animal | 1 | 2013 | 2117 | 0.280 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2007 | 173 | 0.280 |
Why?
|
| PTEN Phosphohydrolase | 6 | 2015 | 1115 | 0.260 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 258 | 0.250 |
Why?
|
| Cell Cycle | 6 | 2013 | 2937 | 0.250 |
Why?
|
| Animals | 58 | 2021 | 167940 | 0.250 |
Why?
|
| Peritonitis | 3 | 2020 | 370 | 0.250 |
Why?
|
| Cell Separation | 6 | 2017 | 1720 | 0.250 |
Why?
|
| RGS Proteins | 1 | 2005 | 75 | 0.240 |
Why?
|
| Receptors, Complement | 1 | 2005 | 253 | 0.240 |
Why?
|
| Mice | 46 | 2021 | 81216 | 0.240 |
Why?
|
| Blood Grouping and Crossmatching | 6 | 2018 | 100 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 8 | 2024 | 2696 | 0.240 |
Why?
|
| Myeloma Proteins | 2 | 1995 | 71 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 7 | 2024 | 5644 | 0.230 |
Why?
|
| Cryoglobulins | 11 | 1995 | 58 | 0.230 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 4554 | 0.230 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 206 | 0.230 |
Why?
|
| Escherichia coli Infections | 2 | 2020 | 524 | 0.230 |
Why?
|
| Anemia, Sickle Cell | 2 | 2024 | 1056 | 0.220 |
Why?
|
| Cell Differentiation | 17 | 2020 | 11480 | 0.220 |
Why?
|
| Plasmapheresis | 3 | 1991 | 206 | 0.220 |
Why?
|
| Blood Banks | 3 | 1996 | 108 | 0.210 |
Why?
|
| Transcription Factors | 7 | 2021 | 12100 | 0.210 |
Why?
|
| Base Sequence | 19 | 2005 | 12447 | 0.210 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 4 | 1997 | 112 | 0.210 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 1995 | 886 | 0.210 |
Why?
|
| Phosphorylation | 8 | 2010 | 8314 | 0.200 |
Why?
|
| Amino Acid Sequence | 19 | 2021 | 13456 | 0.200 |
Why?
|
| Flow Cytometry | 8 | 2017 | 5873 | 0.200 |
Why?
|
| Leukemia | 2 | 2009 | 1522 | 0.200 |
Why?
|
| Stromal Cells | 5 | 2012 | 1327 | 0.200 |
Why?
|
| Reactive Oxygen Species | 4 | 2017 | 2138 | 0.190 |
Why?
|
| Mice, Knockout | 14 | 2015 | 14396 | 0.190 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 657 | 0.190 |
Why?
|
| Receptors, CCR5 | 2 | 2002 | 487 | 0.190 |
Why?
|
| Molecular Sequence Data | 20 | 1999 | 17628 | 0.180 |
Why?
|
| Splenomegaly | 2 | 2020 | 189 | 0.180 |
Why?
|
| Fetal Blood | 5 | 2013 | 1343 | 0.180 |
Why?
|
| HIV Seropositivity | 2 | 1999 | 955 | 0.180 |
Why?
|
| DNA, Complementary | 6 | 2014 | 1993 | 0.180 |
Why?
|
| Multipotent Stem Cells | 2 | 2012 | 200 | 0.180 |
Why?
|
| Bone Marrow Purging | 3 | 1996 | 108 | 0.170 |
Why?
|
| Integrin alpha4beta1 | 3 | 2012 | 119 | 0.170 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2020 | 121 | 0.170 |
Why?
|
| Blood Component Removal | 3 | 2000 | 132 | 0.170 |
Why?
|
| Adult Stem Cells | 2 | 2013 | 221 | 0.170 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2007 | 694 | 0.170 |
Why?
|
| Embryonic Stem Cells | 2 | 2021 | 1262 | 0.160 |
Why?
|
| Apoptosis | 10 | 2021 | 9497 | 0.160 |
Why?
|
| Cell Death | 4 | 2021 | 1670 | 0.160 |
Why?
|
| Humans | 124 | 2024 | 760261 | 0.160 |
Why?
|
| Carbohydrates | 2 | 1993 | 388 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 7 | 2000 | 1075 | 0.160 |
Why?
|
| Lymphoma, B-Cell | 4 | 1995 | 935 | 0.160 |
Why?
|
| Zinc Fingers | 1 | 2021 | 568 | 0.160 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 1998 | 71 | 0.160 |
Why?
|
| Cell Line, Transformed | 6 | 2009 | 871 | 0.160 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2005 | 2415 | 0.160 |
Why?
|
| HIV-2 | 1 | 1999 | 156 | 0.150 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18968 | 0.150 |
Why?
|
| Hemagglutinins | 2 | 1995 | 113 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 11 | 2017 | 22025 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 13 | 2001 | 9196 | 0.150 |
Why?
|
| Histone Demethylases | 1 | 2021 | 323 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 1483 | 0.150 |
Why?
|
| Immunoglobulin G | 5 | 2000 | 4546 | 0.150 |
Why?
|
| Neutropenia | 2 | 2021 | 884 | 0.150 |
Why?
|
| Multigene Family | 3 | 1999 | 1079 | 0.150 |
Why?
|
| Hematology | 1 | 2001 | 241 | 0.140 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2017 | 49 | 0.140 |
Why?
|
| Immunoglobulin kappa-Chains | 3 | 1992 | 169 | 0.140 |
Why?
|
| Escherichia coli | 3 | 2020 | 4223 | 0.140 |
Why?
|
| Virus Activation | 1 | 1999 | 319 | 0.140 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 2 | 2012 | 225 | 0.140 |
Why?
|
| Blood Component Transfusion | 2 | 2000 | 141 | 0.140 |
Why?
|
| ABO Blood-Group System | 3 | 2018 | 369 | 0.140 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 58 | 0.140 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2015 | 114 | 0.140 |
Why?
|
| Homeostasis | 5 | 2020 | 3305 | 0.130 |
Why?
|
| Stem Cell Factor | 2 | 2015 | 198 | 0.130 |
Why?
|
| Integrases | 2 | 2010 | 516 | 0.130 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 8945 | 0.130 |
Why?
|
| Antibodies, Anti-Idiotypic | 3 | 1995 | 357 | 0.130 |
Why?
|
| Cell Transformation, Viral | 4 | 1992 | 526 | 0.130 |
Why?
|
| HIV-1 | 3 | 2000 | 6850 | 0.130 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2014 | 323 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 3 | 2000 | 533 | 0.130 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 | 2009 | 1628 | 0.130 |
Why?
|
| Cyclophosphamide | 5 | 1999 | 2220 | 0.130 |
Why?
|
| Clone Cells | 7 | 1995 | 1663 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 1996 | 545 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1999 | 661 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8498 | 0.120 |
Why?
|
| Cloning, Molecular | 7 | 2000 | 4172 | 0.120 |
Why?
|
| Chemokines, CC | 2 | 2006 | 283 | 0.120 |
Why?
|
| Gammaretrovirus | 1 | 2014 | 24 | 0.120 |
Why?
|
| Radiation Chimera | 2 | 2011 | 216 | 0.120 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2014 | 23 | 0.120 |
Why?
|
| Signal Transduction | 11 | 2016 | 23363 | 0.120 |
Why?
|
| Glutathione | 1 | 2017 | 582 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 9 | 2000 | 6067 | 0.120 |
Why?
|
| Ubiquitination | 2 | 2011 | 1010 | 0.120 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2015 | 162 | 0.120 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1745 | 0.120 |
Why?
|
| Blotting, Southern | 5 | 1992 | 778 | 0.110 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 2 | 2005 | 88 | 0.110 |
Why?
|
| Phosphatidylinositol Phosphates | 3 | 2015 | 202 | 0.110 |
Why?
|
| 16,16-Dimethylprostaglandin E2 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Cold Temperature | 7 | 1993 | 780 | 0.110 |
Why?
|
| Lymphocytes | 5 | 2012 | 2612 | 0.110 |
Why?
|
| Cell Lineage | 4 | 2013 | 2525 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2000 | 2755 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2021 | 11708 | 0.110 |
Why?
|
| Chemokines | 3 | 2005 | 962 | 0.110 |
Why?
|
| P Blood-Group System | 2 | 1994 | 3 | 0.110 |
Why?
|
| Genes, Reporter | 3 | 2014 | 1531 | 0.110 |
Why?
|
| HIV Core Protein p24 | 1 | 1993 | 245 | 0.110 |
Why?
|
| Spleen | 5 | 2013 | 2298 | 0.110 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 1993 | 85 | 0.110 |
Why?
|
| Blood Cells | 2 | 1994 | 305 | 0.110 |
Why?
|
| Antibody Specificity | 6 | 1993 | 1061 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 1135 | 0.100 |
Why?
|
| Antigens, Differentiation | 2 | 2014 | 912 | 0.100 |
Why?
|
| Interleukin-7 | 1 | 2012 | 142 | 0.100 |
Why?
|
| Phagocytosis | 2 | 2009 | 1536 | 0.100 |
Why?
|
| Research | 1 | 2001 | 1973 | 0.100 |
Why?
|
| Animals, Congenic | 1 | 2011 | 27 | 0.100 |
Why?
|
| Nitroimidazoles | 1 | 2013 | 117 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2011 | 2449 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2007 | 7854 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2000 | 1999 | 0.100 |
Why?
|
| Cell Proliferation | 7 | 2021 | 10434 | 0.100 |
Why?
|
| Immunoblotting | 3 | 2007 | 1649 | 0.100 |
Why?
|
| Immunoprecipitation | 3 | 2009 | 877 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2414 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 999 | 0.100 |
Why?
|
| Cyclohexanones | 1 | 2011 | 29 | 0.090 |
Why?
|
| Erythrocyte Membrane | 1 | 1993 | 439 | 0.090 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 414 | 0.090 |
Why?
|
| Transfection | 5 | 2009 | 5782 | 0.090 |
Why?
|
| Lymphocyte Activation | 5 | 1996 | 5498 | 0.090 |
Why?
|
| Mice, SCID | 5 | 2021 | 2627 | 0.090 |
Why?
|
| Ki-67 Antigen | 1 | 2013 | 631 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2013 | 305 | 0.090 |
Why?
|
| Bacteriophages | 1 | 1994 | 373 | 0.090 |
Why?
|
| Immunoglobulins | 2 | 1993 | 863 | 0.090 |
Why?
|
| Mice, Inbred NOD | 4 | 2021 | 1837 | 0.090 |
Why?
|
| Lymphopenia | 1 | 2012 | 280 | 0.090 |
Why?
|
| Muscles | 5 | 2002 | 1581 | 0.090 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 568 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2018 | 1799 | 0.090 |
Why?
|
| Rheumatoid Factor | 1 | 1991 | 185 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2005 | 1246 | 0.090 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2010 | 58 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3613 | 0.090 |
Why?
|
| Cytomegalovirus Infections | 2 | 1999 | 831 | 0.090 |
Why?
|
| Receptors, CCR7 | 2 | 2008 | 108 | 0.090 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 1996 | 1378 | 0.090 |
Why?
|
| Femur | 2 | 2013 | 1302 | 0.090 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 663 | 0.090 |
Why?
|
| Triterpenes | 1 | 2010 | 81 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 2641 | 0.090 |
Why?
|
| Teratoma | 1 | 2012 | 403 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 4494 | 0.080 |
Why?
|
| Antibodies, Anticardiolipin | 2 | 2000 | 62 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2014 | 699 | 0.080 |
Why?
|
| RNA Interference | 2 | 2009 | 2846 | 0.080 |
Why?
|
| Multiple Myeloma | 3 | 1995 | 5131 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2009 | 2473 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2021 | 4374 | 0.080 |
Why?
|
| Fibrinogen | 2 | 1993 | 887 | 0.080 |
Why?
|
| Receptors, Interleukin-21 | 1 | 2008 | 32 | 0.080 |
Why?
|
| Leukocytes | 2 | 2000 | 2030 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 620 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1977 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2368 | 0.080 |
Why?
|
| Immunoglobulin A | 1 | 1992 | 978 | 0.080 |
Why?
|
| Erythropoietin | 1 | 1993 | 720 | 0.080 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 2 | 1987 | 130 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 2021 | 6131 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6543 | 0.080 |
Why?
|
| Cryopreservation | 4 | 2017 | 720 | 0.080 |
Why?
|
| Cysteine | 3 | 2017 | 897 | 0.080 |
Why?
|
| STAT5 Transcription Factor | 1 | 2009 | 264 | 0.080 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 9388 | 0.080 |
Why?
|
| Gene Expression | 6 | 2014 | 7592 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2297 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 9590 | 0.080 |
Why?
|
| Inflammation | 3 | 2017 | 10757 | 0.080 |
Why?
|
| Pneumonia, Bacterial | 1 | 2011 | 319 | 0.080 |
Why?
|
| Cell Line | 10 | 2009 | 15626 | 0.080 |
Why?
|
| Utilization Review | 1 | 1989 | 383 | 0.080 |
Why?
|
| Program Development | 1 | 2014 | 1297 | 0.070 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Leukocyte Transfusion | 2 | 2021 | 56 | 0.070 |
Why?
|
| Refrigeration | 1 | 2007 | 27 | 0.070 |
Why?
|
| Peer Review | 1 | 1989 | 218 | 0.070 |
Why?
|
| Myelopoiesis | 1 | 2008 | 134 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2007 | 109 | 0.070 |
Why?
|
| Antigens, CD34 | 3 | 2014 | 652 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2021 | 1617 | 0.070 |
Why?
|
| Nucleic Acid Heteroduplexes | 2 | 1997 | 46 | 0.070 |
Why?
|
| Chemokine CCL19 | 1 | 2006 | 35 | 0.070 |
Why?
|
| Splenectomy | 2 | 1987 | 391 | 0.070 |
Why?
|
| Tissue Adhesives | 1 | 1988 | 172 | 0.070 |
Why?
|
| Chemokine CCL21 | 1 | 2006 | 51 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 394 | 0.070 |
Why?
|
| Amino Acid Motifs | 2 | 2021 | 929 | 0.070 |
Why?
|
| T-Lymphocytes | 4 | 2014 | 10183 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4437 | 0.070 |
Why?
|
| Tubulin | 1 | 2010 | 692 | 0.070 |
Why?
|
| Receptors, CXCR5 | 1 | 2006 | 88 | 0.070 |
Why?
|
| Blood Preservation | 1 | 2007 | 168 | 0.070 |
Why?
|
| Receptors, CCR6 | 1 | 2006 | 73 | 0.070 |
Why?
|
| Antigens, Ly | 1 | 2007 | 293 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2008 | 473 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 685 | 0.070 |
Why?
|
| Amniotic Fluid | 1 | 2008 | 378 | 0.070 |
Why?
|
| Anaphylatoxins | 1 | 2005 | 21 | 0.070 |
Why?
|
| Ear, Middle | 1 | 1988 | 337 | 0.070 |
Why?
|
| Myosins | 2 | 1988 | 405 | 0.070 |
Why?
|
| Galactose | 1 | 2007 | 297 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 2651 | 0.060 |
Why?
|
| Enzyme Activation | 3 | 2008 | 3604 | 0.060 |
Why?
|
| Cell Division | 5 | 2011 | 4462 | 0.060 |
Why?
|
| Isoelectric Focusing | 3 | 1991 | 160 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 436 | 0.060 |
Why?
|
| Cell Movement | 6 | 2013 | 5206 | 0.060 |
Why?
|
| von Willebrand Diseases | 1 | 1987 | 132 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2000 | 278 | 0.060 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2005 | 87 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 1694 | 0.060 |
Why?
|
| Cell Migration Inhibition | 1 | 2005 | 97 | 0.060 |
Why?
|
| Phenytoin | 1 | 1986 | 188 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1056 | 0.060 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2005 | 73 | 0.060 |
Why?
|
| Isoantigens | 2 | 2001 | 552 | 0.060 |
Why?
|
| Pyridines | 2 | 2021 | 2877 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3378 | 0.060 |
Why?
|
| Mitosis | 1 | 2010 | 1193 | 0.060 |
Why?
|
| Male | 25 | 2020 | 359413 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2138 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 1995 | 2178 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2009 | 718 | 0.060 |
Why?
|
| Cell Communication | 1 | 2011 | 1642 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2005 | 2866 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2021 | 3105 | 0.060 |
Why?
|
| Immunization | 1 | 2008 | 1228 | 0.060 |
Why?
|
| Lentivirus | 1 | 2007 | 505 | 0.060 |
Why?
|
| Microtubules | 1 | 2010 | 1072 | 0.060 |
Why?
|
| Lymphoma | 2 | 1993 | 1899 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 11902 | 0.060 |
Why?
|
| Glycoproteins | 3 | 2001 | 2208 | 0.060 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 1656 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 4573 | 0.060 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 616 | 0.060 |
Why?
|
| Adult | 24 | 2018 | 219847 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1998 | 3804 | 0.060 |
Why?
|
| Chemokine CXCL2 | 2 | 2016 | 108 | 0.060 |
Why?
|
| Disease Models, Animal | 5 | 2020 | 18134 | 0.050 |
Why?
|
| Antibodies, Neoplasm | 2 | 1995 | 280 | 0.050 |
Why?
|
| Female | 27 | 2020 | 391011 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2007 | 729 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1995 | 1056 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2013 | 2861 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 1994 | 410 | 0.050 |
Why?
|
| Oxygen | 1 | 2014 | 4189 | 0.050 |
Why?
|
| Graft Survival | 1 | 2013 | 3793 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2021 | 2003 | 0.050 |
Why?
|
| Gene Library | 2 | 1995 | 1060 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2011 | 3735 | 0.050 |
Why?
|
| HIV | 2 | 2000 | 1579 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2005 | 534 | 0.050 |
Why?
|
| Transplantation, Autologous | 4 | 1996 | 2120 | 0.050 |
Why?
|
| DNA Primers | 3 | 1995 | 2819 | 0.050 |
Why?
|
| Circadian Rhythm | 1 | 2013 | 2567 | 0.050 |
Why?
|
| Breast Neoplasms | 3 | 1999 | 21065 | 0.050 |
Why?
|
| Hematologic Neoplasms | 1 | 2013 | 1899 | 0.050 |
Why?
|
| Dermatitis, Atopic | 1 | 2008 | 710 | 0.050 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 1983 | 361 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 416 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2006 | 2918 | 0.050 |
Why?
|
| Blood Cell Count | 2 | 2008 | 398 | 0.050 |
Why?
|
| Coronary Artery Bypass | 1 | 1990 | 2273 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1843 | 0.050 |
Why?
|
| Fetus | 2 | 1999 | 1859 | 0.050 |
Why?
|
| Actins | 2 | 2005 | 2049 | 0.050 |
Why?
|
| Blood Substitutes | 1 | 2001 | 57 | 0.050 |
Why?
|
| Stem Cells | 2 | 2007 | 3525 | 0.050 |
Why?
|
| Protein Binding | 4 | 2021 | 9336 | 0.050 |
Why?
|
| Glycolipids | 2 | 1994 | 204 | 0.050 |
Why?
|
| Tyrosine | 1 | 2005 | 1440 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2005 | 498 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3726 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2011 | 2978 | 0.040 |
Why?
|
| Blast Crisis | 2 | 2011 | 101 | 0.040 |
Why?
|
| Reading Frames | 1 | 1999 | 17 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2015 | 9531 | 0.040 |
Why?
|
| Genomics | 1 | 2015 | 5790 | 0.040 |
Why?
|
| Heart | 1 | 2013 | 4392 | 0.040 |
Why?
|
| Herpesvirus 7, Human | 1 | 1999 | 14 | 0.040 |
Why?
|
| beta 2-Glycoprotein I | 1 | 1998 | 28 | 0.040 |
Why?
|
| HIV Antigens | 1 | 2000 | 325 | 0.040 |
Why?
|
| Forecasting | 2 | 2001 | 2931 | 0.040 |
Why?
|
| Protein Transport | 1 | 2005 | 1966 | 0.040 |
Why?
|
| Protein Array Analysis | 1 | 2021 | 401 | 0.040 |
Why?
|
| Bone Marrow Neoplasms | 1 | 1999 | 101 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2014 | 645 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3584 | 0.040 |
Why?
|
| Thiotepa | 2 | 1999 | 66 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 4357 | 0.040 |
Why?
|
| Transplantation | 1 | 2000 | 218 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2000 | 344 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 1991 | 3023 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 11064 | 0.040 |
Why?
|
| Autoantigens | 2 | 1994 | 877 | 0.040 |
Why?
|
| Oligonucleotides | 2 | 1991 | 588 | 0.040 |
Why?
|
| Herpesvirus 6, Human | 1 | 1999 | 96 | 0.040 |
Why?
|
| Models, Biological | 1 | 2014 | 9468 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1201 | 0.040 |
Why?
|
| Proline | 1 | 2000 | 457 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2005 | 1354 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2008 | 1867 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 1987 | 1067 | 0.040 |
Why?
|
| Glutaredoxins | 1 | 2017 | 32 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 2 | 1988 | 132 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2017 | 5039 | 0.040 |
Why?
|
| Antineoplastic Agents | 4 | 2011 | 13629 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2021 | 4264 | 0.040 |
Why?
|
| Hybridomas | 2 | 1992 | 442 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 1999 | 270 | 0.040 |
Why?
|
| Autoimmunity | 2 | 1995 | 1370 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2018 | 93 | 0.040 |
Why?
|
| Antiphospholipid Syndrome | 1 | 1998 | 165 | 0.030 |
Why?
|
| Herpesvirus 8, Human | 1 | 1999 | 255 | 0.030 |
Why?
|
| Pregnancy | 6 | 2013 | 29725 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2011 | 5793 | 0.030 |
Why?
|
| Parental Consent | 1 | 1996 | 63 | 0.030 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1995 | 33 | 0.030 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 1995 | 87 | 0.030 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 1995 | 58 | 0.030 |
Why?
|
| Immunoglobulin mu-Chains | 1 | 1995 | 62 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2000 | 682 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1988 | 3604 | 0.030 |
Why?
|
| Benzamides | 1 | 2021 | 1369 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 859 | 0.030 |
Why?
|
| Plasma | 2 | 1989 | 584 | 0.030 |
Why?
|
| Karyotyping | 2 | 1988 | 1172 | 0.030 |
Why?
|
| Megakaryocytes | 1 | 1999 | 566 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1991 | 3763 | 0.030 |
Why?
|
| Blood Group Incompatibility | 1 | 1996 | 135 | 0.030 |
Why?
|
| Phenotype | 4 | 2005 | 16543 | 0.030 |
Why?
|
| Reference Values | 1 | 2002 | 4920 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2000 | 1400 | 0.030 |
Why?
|
| DNA | 4 | 1998 | 7236 | 0.030 |
Why?
|
| Skin | 1 | 2008 | 4468 | 0.030 |
Why?
|
| Calcium | 2 | 2000 | 5726 | 0.030 |
Why?
|
| Acute Disease | 2 | 2016 | 7268 | 0.030 |
Why?
|
| Phospholipids | 1 | 1998 | 789 | 0.030 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2014 | 85 | 0.030 |
Why?
|
| Cell Survival | 3 | 2014 | 5796 | 0.030 |
Why?
|
| Risk Assessment | 1 | 1996 | 24086 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1995 | 195 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 310 | 0.030 |
Why?
|
| Infant, Newborn | 6 | 2013 | 26168 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 5640 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 1996 | 717 | 0.030 |
Why?
|
| Middle Aged | 15 | 2018 | 220175 | 0.030 |
Why?
|
| Neoplasms | 2 | 2021 | 22066 | 0.030 |
Why?
|
| Adoptive Transfer | 2 | 2008 | 825 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2012 | 2378 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 778 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1994 | 98 | 0.030 |
Why?
|
| Forms and Records Control | 1 | 2014 | 158 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 2 | 1989 | 566 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 2014 | 0.030 |
Why?
|
| Laser Scanning Cytometry | 1 | 2013 | 5 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2002 | 3683 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2017 | 1760 | 0.030 |
Why?
|
| Factor XIII | 1 | 1993 | 59 | 0.030 |
Why?
|
| Hemagglutination | 2 | 1992 | 32 | 0.030 |
Why?
|
| Cattle | 1 | 1999 | 3847 | 0.030 |
Why?
|
| Ligands | 2 | 2016 | 3277 | 0.030 |
Why?
|
| Hemagglutination Tests | 1 | 1992 | 77 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2015 | 278 | 0.030 |
Why?
|
| Immunoelectrophoresis | 1 | 1992 | 104 | 0.030 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2013 | 63 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1993 | 279 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2013 | 60 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2015 | 1870 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 938 | 0.030 |
Why?
|
| Sirolimus | 1 | 2000 | 1548 | 0.030 |
Why?
|
| Cardiolipins | 1 | 1992 | 81 | 0.030 |
Why?
|
| Acetylcholinesterase | 2 | 1983 | 156 | 0.030 |
Why?
|
| Ploidies | 1 | 2013 | 275 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1999 | 3605 | 0.030 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1994 | 465 | 0.030 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 1993 | 95 | 0.030 |
Why?
|
| Epitopes | 1 | 1998 | 2506 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 877 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1995 | 749 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1992 | 130 | 0.020 |
Why?
|
| Lung Injury | 1 | 2016 | 424 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 897 | 0.020 |
Why?
|
| HIV Infections | 2 | 1995 | 17159 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1989 | 299 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1739 | 0.020 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2011 | 37 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1991 | 852 | 0.020 |
Why?
|
| Transgenes | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Platelet Count | 1 | 1994 | 777 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 16905 | 0.020 |
Why?
|
| Introns | 1 | 1993 | 978 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1972 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2013 | 595 | 0.020 |
Why?
|
| Caspases | 1 | 2014 | 878 | 0.020 |
Why?
|
| Carboplatin | 1 | 1994 | 789 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 4286 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2013 | 358 | 0.020 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2010 | 36 | 0.020 |
Why?
|
| Education | 1 | 2013 | 535 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2013 | 1765 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2017 | 1271 | 0.020 |
Why?
|
| Phosphatidylinositols | 1 | 2011 | 282 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2014 | 450 | 0.020 |
Why?
|
| Proteins | 1 | 2005 | 6030 | 0.020 |
Why?
|
| Perinatology | 1 | 1990 | 62 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1994 | 1600 | 0.020 |
Why?
|
| Alleles | 3 | 2014 | 6900 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2011 | 426 | 0.020 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 1989 | 92 | 0.020 |
Why?
|
| Osteoblasts | 1 | 2015 | 1142 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 71 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2015 | 1112 | 0.020 |
Why?
|
| United States | 6 | 2014 | 72363 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1990 | 1143 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2009 | 242 | 0.020 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2009 | 114 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 2214 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2012 | 792 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2013 | 730 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 1999 | 3601 | 0.020 |
Why?
|
| Amniocentesis | 1 | 2008 | 115 | 0.020 |
Why?
|
| Protein Stability | 1 | 2010 | 566 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2012 | 718 | 0.020 |
Why?
|
| Kinetics | 3 | 1986 | 6378 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2008 | 110 | 0.020 |
Why?
|
| Tympanoplasty | 1 | 1988 | 71 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 1511 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1998 | 2823 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 2 | 1987 | 1870 | 0.020 |
Why?
|
| Aged | 8 | 2021 | 168995 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2874 | 0.020 |
Why?
|
| Bleeding Time | 1 | 1987 | 84 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 934 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 2532 | 0.020 |
Why?
|
| Dithiothreitol | 1 | 1987 | 95 | 0.020 |
Why?
|
| Factor VIII | 1 | 1989 | 350 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2013 | 1137 | 0.020 |
Why?
|
| Adiposity | 1 | 2017 | 1851 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2000 | 4168 | 0.020 |
Why?
|
| Placenta | 1 | 1996 | 1701 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2008 | 678 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1705 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 5784 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1986 | 176 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1304 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2007 | 363 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 1032 | 0.020 |
Why?
|
| Blood Volume | 1 | 1988 | 550 | 0.020 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 462 | 0.020 |
Why?
|
| Endothelium | 1 | 2009 | 764 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 1737 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1989 | 674 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 1990 | 657 | 0.020 |
Why?
|
| Lung | 2 | 2016 | 9989 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 1500 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2010 | 1755 | 0.020 |
Why?
|
| Citrates | 1 | 1986 | 136 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 372 | 0.020 |
Why?
|
| Body Temperature | 1 | 1989 | 777 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 2042 | 0.020 |
Why?
|
| Shock | 1 | 1988 | 318 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 1988 | 389 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 716 | 0.020 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2007 | 251 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1987 | 1628 | 0.020 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1985 | 55 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 3317 | 0.020 |
Why?
|
| Hepatomegaly | 1 | 1985 | 84 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 4416 | 0.020 |
Why?
|
| Hypergammaglobulinemia | 1 | 1985 | 72 | 0.020 |
Why?
|
| Integrin alpha4 | 1 | 2005 | 87 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 983 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4317 | 0.020 |
Why?
|
| Selectins | 1 | 2005 | 101 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 2197 | 0.020 |
Why?
|
| Osteosclerosis | 1 | 1985 | 42 | 0.020 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1985 | 82 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2014 | 1442 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2013 | 4814 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2009 | 731 | 0.010 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 94 | 0.010 |
Why?
|
| Retroviridae | 1 | 2007 | 850 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1990 | 1439 | 0.010 |
Why?
|
| Fever | 1 | 1992 | 1618 | 0.010 |
Why?
|
| Cytarabine | 1 | 1986 | 696 | 0.010 |
Why?
|
| Mathematics | 1 | 1986 | 708 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2015 | 2560 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 2011 | 8551 | 0.010 |
Why?
|
| Algorithms | 2 | 2018 | 13967 | 0.010 |
Why?
|
| Anemia | 1 | 1993 | 1511 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1999 | 12762 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1988 | 593 | 0.010 |
Why?
|
| Rubella | 1 | 1984 | 55 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3800 | 0.010 |
Why?
|
| Quality Control | 1 | 1986 | 827 | 0.010 |
Why?
|
| Interleukins | 1 | 2008 | 782 | 0.010 |
Why?
|
| Treatment Outcome | 4 | 2014 | 64947 | 0.010 |
Why?
|
| Glycosylation | 1 | 2007 | 1097 | 0.010 |
Why?
|
| Regeneration | 1 | 2013 | 1506 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 1987 | 349 | 0.010 |
Why?
|
| Liver | 1 | 1999 | 7512 | 0.010 |
Why?
|
| Resuscitation | 1 | 1988 | 662 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2008 | 708 | 0.010 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1993 | 1401 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1983 | 34 | 0.010 |
Why?
|
| Collagen Diseases | 1 | 1983 | 39 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1986 | 499 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 1995 | 3046 | 0.010 |
Why?
|
| Myasthenia Gravis | 1 | 1986 | 213 | 0.010 |
Why?
|
| Monocytes | 1 | 1992 | 2574 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2012 | 4127 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1991 | 4109 | 0.010 |
Why?
|
| Mutation | 3 | 2014 | 29950 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2009 | 1602 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 1347 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 4900 | 0.010 |
Why?
|
| Microsurgery | 1 | 1988 | 791 | 0.010 |
Why?
|
| Gestational Age | 2 | 2008 | 3564 | 0.010 |
Why?
|
| Adrenal Insufficiency | 1 | 1985 | 192 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1994 | 3731 | 0.010 |
Why?
|
| Muscle Contraction | 2 | 1988 | 1201 | 0.010 |
Why?
|
| DEAE-Cellulose | 1 | 1982 | 1 | 0.010 |
Why?
|
| Receptors, Cholinergic | 1 | 1983 | 244 | 0.010 |
Why?
|
| DEAE-Dextran | 1 | 1982 | 9 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1986 | 1250 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1746 | 0.010 |
Why?
|
| Complement C4 | 1 | 1983 | 244 | 0.010 |
Why?
|
| Prenatal Care | 1 | 1990 | 1128 | 0.010 |
Why?
|
| Internet | 1 | 2014 | 3074 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2015 | 3537 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 2192 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1986 | 1616 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1986 | 1455 | 0.010 |
Why?
|
| Adolescent | 4 | 2018 | 87747 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1986 | 1690 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2011 | 2563 | 0.010 |
Why?
|
| Cellulose | 1 | 1982 | 118 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 1395 | 0.010 |
Why?
|
| Infant | 2 | 2014 | 36030 | 0.010 |
Why?
|
| Emergencies | 1 | 1988 | 1217 | 0.010 |
Why?
|
| Recurrence | 1 | 1994 | 8487 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1999 | 9274 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 3774 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 1993 | 2469 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 10340 | 0.010 |
Why?
|
| Complement C3 | 1 | 1983 | 451 | 0.010 |
Why?
|
| Time Factors | 2 | 1994 | 40133 | 0.010 |
Why?
|
| Biological Products | 1 | 2010 | 914 | 0.010 |
Why?
|
| Hylobates | 1 | 2000 | 13 | 0.010 |
Why?
|
| Cebus | 1 | 2000 | 16 | 0.010 |
Why?
|
| Neuromuscular Diseases | 1 | 1983 | 256 | 0.010 |
Why?
|
| Gorilla gorilla | 1 | 2000 | 29 | 0.010 |
Why?
|
| Binding Sites | 1 | 2009 | 6050 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2008 | 2668 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1982 | 565 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2000 | 148 | 0.010 |
Why?
|
| Myocardium | 1 | 2013 | 4688 | 0.010 |
Why?
|
| Dextrans | 1 | 1982 | 574 | 0.010 |
Why?
|
| Risk Factors | 3 | 1992 | 74269 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 1985 | 665 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 6226 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 1986 | 1767 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 2000 | 224 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 2000 | 363 | 0.010 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2000 | 91 | 0.010 |
Why?
|
| Parathyroid Hormone | 1 | 1986 | 1797 | 0.010 |
Why?
|
| Genetic Variation | 2 | 1992 | 6540 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2000 | 211 | 0.010 |
Why?
|
| Integrins | 1 | 2003 | 840 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 58673 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 8018 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 2804 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1985 | 708 | 0.010 |
Why?
|
| Macaca | 1 | 2000 | 409 | 0.010 |
Why?
|
| Collagen | 1 | 2007 | 2635 | 0.010 |
Why?
|
| Hypogonadism | 1 | 1985 | 800 | 0.010 |
Why?
|
| Syndrome | 1 | 1985 | 3278 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 474 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58947 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 478 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3443 | 0.010 |
Why?
|
| Colitis | 1 | 1986 | 1229 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 1987 | 2143 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8058 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2007 | 5201 | 0.010 |
Why?
|
| Hospitals | 1 | 1989 | 3929 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1992 | 3606 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2003 | 1726 | 0.010 |
Why?
|
| Survival Rate | 1 | 2010 | 12806 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 5396 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1999 | 619 | 0.010 |
Why?
|
| Public Policy | 1 | 2000 | 560 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 1228 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1999 | 54263 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2010 | 5230 | 0.010 |
Why?
|
| Haplotypes | 1 | 2001 | 2764 | 0.010 |
Why?
|
| Child | 2 | 2013 | 79758 | 0.010 |
Why?
|
| Vascular Diseases | 1 | 1983 | 1180 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1987 | 3201 | 0.010 |
Why?
|
| Immune System | 1 | 2000 | 795 | 0.010 |
Why?
|
| Binding Sites, Antibody | 2 | 1986 | 337 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 1041 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 4923 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 13505 | 0.010 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 1679 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 1790 | 0.010 |
Why?
|
| Cholesterol | 1 | 1983 | 2925 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2932 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14656 | 0.010 |
Why?
|
| Europe | 1 | 2000 | 3433 | 0.010 |
Why?
|
| Seizures | 1 | 1986 | 2916 | 0.010 |
Why?
|
| Macrophages | 1 | 2007 | 5745 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1234 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2000 | 1591 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 1999 | 3160 | 0.010 |
Why?
|
| Exons | 1 | 1997 | 2391 | 0.010 |
Why?
|
| Mastectomy | 1 | 1999 | 1834 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1999 | 3531 | 0.010 |
Why?
|
| Fetomaternal Transfusion | 1 | 1990 | 10 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3665 | 0.010 |
Why?
|
| Rho(D) Immune Globulin | 1 | 1990 | 34 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42034 | 0.010 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1990 | 62 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1985 | 9283 | 0.010 |
Why?
|
| Cancer Vaccines | 1 | 1996 | 1044 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 1999 | 6830 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1990 | 616 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10829 | 0.000 |
Why?
|
| Isoelectric Point | 1 | 1986 | 76 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1990 | 321 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1999 | 10185 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1986 | 297 | 0.000 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1986 | 59 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1986 | 915 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1986 | 412 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1999 | 11141 | 0.000 |
Why?
|
| Molecular Weight | 1 | 1986 | 2186 | 0.000 |
Why?
|
| Antigens, CD | 1 | 1993 | 4002 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1983 | 293 | 0.000 |
Why?
|
| Octoxynol | 1 | 1982 | 77 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1986 | 1549 | 0.000 |
Why?
|
| Genotype | 1 | 1997 | 12959 | 0.000 |
Why?
|
| Tetrodotoxin | 1 | 1983 | 246 | 0.000 |
Why?
|
| Microbial Collagenase | 1 | 1982 | 113 | 0.000 |
Why?
|
| Cell Aggregation | 1 | 1982 | 239 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 36247 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 1999 | 15827 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1982 | 662 | 0.000 |
Why?
|
| DNA, Single-Stranded | 1 | 1982 | 360 | 0.000 |
Why?
|
| Membrane Potentials | 1 | 1983 | 1095 | 0.000 |
Why?
|
| Chick Embryo | 1 | 1982 | 981 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1982 | 941 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 13249 | 0.000 |
Why?
|
| Prognosis | 1 | 1999 | 29636 | 0.000 |
Why?
|
| Cricetinae | 1 | 1982 | 2427 | 0.000 |
Why?
|
| Dogs | 1 | 1982 | 3843 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1982 | 1188 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1982 | 1667 | 0.000 |
Why?
|
| Brain | 1 | 2002 | 26912 | 0.000 |
Why?
|
| Age Factors | 1 | 1988 | 18415 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1982 | 2250 | 0.000 |
Why?
|
| Kidney | 1 | 1982 | 7072 | 0.000 |
Why?
|